Biological: ProHema-CB
FT1050-04
Phase 1 mab terminated
Quick answer
Biological: ProHema-CB for Hematologic Malignancies is a Phase 1 program (mab) at FATE THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- FATE THERAPEUTICS INC
- Indication
- Hematologic Malignancies
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated